Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AQUATIC: Aspirin vs Placebo with OAC in Stabilized CAD
NCT04217447Phase 3Terminated
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- May 2020
- Primary completion
- Oct 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in coronary artery disease (CAD), sponsored by Centre Hospitalier Universitaire de Brest. Started May 2020; status: terminated.
02
Drugs
aspirin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04217447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04217447.